Vermillion Reports $73K in Q1 Revenues

The company also said its net loss rose to $11.6 million in the quarter, the first in which it and Quest Diagnostics began marketing its OVA1 test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories